Fusion Pharmaceuticals Inc (FUSN) Stock Falls -15.43% This Week; Should You Buy?

Fusion Pharmaceuticals Inc (FUSN) stock is down -62.86% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives FUSN stock a score of 0 out of a possible 100.

That rank is chiefly influenced by a short-term technical score of 0. FUSN's rank also includes a long-term technical score of 0.

FUSN has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on FUSN!

See Full FUSN Report

What's Happening with FUSN Stock Today

Fusion Pharmaceuticals Inc (FUSN) stock has fallen -8.51% while the S&P 500 is up 0.55% as of 3:19 PM on Thursday, Jun 23. FUSN is down -$0.28 from the previous closing price of $3.23 on volume of 53,331 shares. Over the past year the S&P 500 is lower by -10.88% while FUSN is down -62.86%. FUSN lost -$0.83 per share in the over the last 12 months. Click Here to get the full Stock Report for Fusion Pharmaceuticals Inc stock.